NTUS News and Press, Natus Medical Incorporated From 09/28/21

Although the Fed’s continued monetary policy support should drive the economic recovery, due to the expected market volatility in the near term, it could be wise to bet on value stocks, as highly-priced stocks might witness a pullback. Arkema (ARKAY), Industrias Bachoco (IBA), Natus Me...

PLEASANTON, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders f...

Natus Medical (NTUS) develops products and services for the health of babies. This is one area where people are willing to spend as much money as necessary which means NTUS has major upside or could be an acquisition target. Medical device stocks tend to outperform in the long term but ar...

The medical devices industry is in recovery mode this year with the rescheduling of surgeries that were placed on hold during the height of the COVID-19 pandemic. Although the pace of recovery is expected to slow in the near term due to the resurgence of COVID-19 cases, impressive breakthroug...

PLEASANTON, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...

Natus Medical Incorporated (NTUS) Q2 2021 Earnings Conference Call August 6, 2021 8:00 AM ET Company Participants Jonathan Kennedy – President and Chief Executive Officer Drew Davies – Executive Vice President & Chief Financial Officer Conference Call Participants Jayson Bed...

The following slide deck was published by Natus Medical Incorporated in conjunction with their 2021 Q2 earnings call. For further details see: Natus Medical Incorporated 2021 Q2 - Results - Earnings Call Presentation

Image source: The Motley Fool. Natus Medical Inc (NASDAQ: NTUS) Q2 2021 Earnings Call Aug 6, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Natus Medical Inc (NTUS) Q2 2021 Earnings Call Transcript

Natus Medical (NASDAQ:NTUS): Q2 Non-GAAP EPS of $0.29 in-line; GAAP EPS of $0.10 misses by $0.07. Revenue of $115.97M (+36.8% Y/Y) beats by $0.87M. Press Release For further details see: Natus Medical EPS in-line, beats on revenue

PLEASANTON, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...